C Bogdanici | PubMed Health

PubMed2001

[Temporal arteritis with giant cells].

Giant cell (temporal) arteritis remains an enigmatic but a very serious systemic vasculitis which can lead to total, irreversible blindness if not diagnosed and treated swiftly. The characteristic granulomatous inflammation of the vessel wall of large and medium-sized arteries is present. To maintain high standards of management, ophthalmologists need to be aware of the clinical available diagnostic tests and treatment strategies. Corticosteroids remain the treatment of choice.

Anti-Inflammatory Agents↗

PubMed2000

[Actualities in retinoblastoma's treatment].

The management of retinoblastoma should be undertaken by multidisciplinary health care team. Ophthalmopediatrics and ocular oncologists have sought effective alternative methods for treating retinoblastoma. The management of retinoblastoma has been changed significant past few years. Recently, advances in understanding of retinoblastoma have led to trials of new treatment modalities aimed at decreasing morbidity and continuing excellent survival. This review tries to present the new and modern aspects in retinoblastoma therapy.

Antineoplastic Combined Chemotherapy Protocols↗

PubMed1997

[Primary trabeculectomy for early-onset congenital glaucomas].

OBJECTIVE: Analysis of the results of primary trabeculectomy in the treatment of congenital glaucoma. MATERIALS AND METHOD: Retrospective study of a series of 62 patients with primary trabeculectomy for congenital glaucoma, with a mean follow-up period of 2.22+/-2.86 years. RESULTS: The last controlled intraocular pressure (IOP) was higher for the patients in the age group 0-1 year (16.9+/-8) as compared with the patients older than 1 year (14.9+/-7). An intraocular pressure < or = 20 mmHg without additional medication has been found in 58.3% of the cases in the 0-1 year age group, versus 65.8% in the group of patients older than 1 year. The number of reoperations was higher in the 0-1 year age group (14), as compared with the group of patients older than 1 year (8). The rate of qualified therapeutic success (IOP < or = 20 mmHg) was 79.1% in the 0-1 year age group, versus 85.5% in the group of patients older than 1 year. CONCLUSIONS: Primary trabeculectomy is effective in the treatment of congenital glaucoma. The poorer results in the group of patients under 1 year of age is correlated with disease severity. The rate of favorable results is increased by reoperation, the majority of surgical failures belonging to the group of patients who needed reoperations.

Age of Onset↗